CD8A and neoplasm: Moreover, the presence of CD11b+/CD14−/CD15+/CD33+ granulocytic‐MDSCs and CD14+/S100A9+ monocytic‐MDSCs, expressing L‐arginase and nitric oxide synthase, in the tumor area, resulted in suppression of CD8+ T cells and correlated with reduced survival.36, 37